Picture of Dongwha Pharm Co logo

000020 Dongwha Pharm Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareConservativeSmall CapNeutral

Annual cashflow statement for Dongwha Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line19,58321,59128,2372,1463,842
Depreciation
Amortisation
Non-Cash Items16,23519,00691422,48911,527
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-11,880-23,886-13,880-48,307-21,636
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities36,03129,22129,167-4,00315,699
Capital Expenditures-24,774-20,091-26,346-74,064-55,299
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-640-23,18129,209-72514,119
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-25,414-43,2722,863-74,789-41,180
Financing Cash Flow Items-5.55-3,121
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-8,783-12,0135,86631,35613,399
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,883-26,13337,970-46,661-12,351